Riskpilot← Back to searchSign inGet full accessGävle Medicinkonsult AB
ABDissolvedOrg 5568532203General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2024
SEK 0
EBITDA margin
—
-152% vs 2023
Equity ratio
83.4%
Financial strength
Net profit 2024
SEK 45K
-64% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -103K | -152% |
| Net profit | SEK 45K | -64% |
| Total assets | SEK 281K | -58% |
| Equity | SEK 234K | -41% |
| Employees | 1 | — |
Legal name
Gävle Medicinkonsult AB
Org number
5568532203
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 maj 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska utföra läkar- och sjukskötersketjänster, bedriva utbildning inom sjukvård, handel med värdepapper samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 298 | 296 | 0 |
| Staff expenses | — | — | −44 | −31 | −0 |
| EBITDA | −28 | −25 | 190 | 199 | −103 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −28 | −25 | 190 | 199 | −103 |
| Net financials | −96 | — | 117 | 11 | 2 |
| Profit before tax | 90 | 84 | 343 | 157 | 61 |
| Tax | −31 | −19 | −48 | −33 | −16 |
| Net profit | 59 | 65 | 295 | 125 | 45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 743 | 551 | 726 | 668 | 281 |
| Equity | 456 | 360 | 465 | 394 | 234 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 32 | 44 | 152 | 112 | 46 |
| Total debt | 32 | 44 | 152 | 112 | 46 |
EBITDA margin
-10290300.0%
This company
15.8%
Market median
-65128581% vs market
20202024
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
19.3%
This company
18.4%
Market median
+5% vs market
20202024
Net profit margin
4519900.0%
This company
8.1%
Market median
+55801135% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gävle Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bo Hjalmar Sundelöf | Board of Directors | 0 companies |
| Lisa Birgitta Kollberg | Deputy Board Member | 0 companies |
| Nils Åke Martin Junghem | Board of Directors | 0 companies |
| Ulla Barbro Sundelöf | Deputy Board Member | 0 companies |